ArticleBriefings in bioinformatics2024
CPARI: a novel approach combining cell partitioning with absolute and relative imputation to address dropout in single-cell RNA-seq data.
Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PbImpute: Precise Zero Discrimination and Balanced Imputation in Single-Cell RNA Sequencing Data.Journal of chemical information and modeling · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A key challenge in analyzing single-cell RNA sequencing data is the large number of false zeros, known as "dropout zeros", which are caused by technical limitations such as shallow sequencing depth or inefficient mRNA capture. To address this challenge, we propose a novel imputation model called CPARI, which combines cell partitioning with our designed absolute and relative imputation methods. Initially, CPARI employs a new approach to select highly variable genes and constructs an average consensus matrix using C-mean fuzzy clustering-based blockchain technology to obtain results at different resolutions. Hierarchical clustering is then applied to further refine these blocks, resulting in well-defined cellular partitions. Subsequently, CPARI identifies dropout events and determines the imputation positions of these identified zeros. An autoencoder is trained within each cellular block to learn gene features and reconstruct data. Our uniquely defined absolute imputation technique is first applied to the identified positions, followed by our relative imputation technique to address remaining dropout zeros, ensuring that both global consistency and local variation are maintained. Through comprehensive analyses conducted on simulated and real scRNA-seq datasets, including quantitative assessment, differential expression analysis, cell clustering, cell trajectory inference, robustness evaluation, and large-scale data imputation, CPARI demonstrates superior performance compared to 12 other art-of-state imputation models. Additionally, ablation experiments further confirm the significance and necessity of both the cell partitioning and relative imputation components of CPARI. Notably, CPARI as a new denoising approach could distinguish between real biological zeros and dropout zeros and minimize false positives, and maximize the accuracy of imputation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.